Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 346 participants.

Also called NCT01653600

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 346 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01653600
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01653600. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2014-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Self-Expanding Nitinol S.M.A.R.T CONTROL Stent Versus Life Stent For The Atherosclerotic Femoro-Popliteal Arterial Disease
Acronym
SENS-FP-2
Condition
Peripheral Arterial Disease
Condition
Atherosclerosis
Intervention (Device)
S.M.A.R.T CONTROL Stent
Intervention (Device)
LifeStent
Lead sponsor
Korea University Guro Hospital (class: other)

Record details

Record id
cardio:ct-nct01653600
Content hash
a32fbd72b5932ea121d91c3b9e14e406a3d8ef0a06884080cb20b51d672c836e